
Senior Director and Head of Employer and Labor Partnerships at GRAIL
The U.S. spends more than $200 billion annually on cancer. There are direct treatment costs, but there are also indirect costs including lost productivity and increased absenteeism.
Productivity losses alone cost organizations $18 billion a year.
Employers can reduce cancer costs and improve outcomes through early detection. Listen to the second podcast in a three-part series on cancer in the workplace as Grail's Ailene Bui explains why cancer costs are increasing and what employers can do to fight back.
- The direct and indirect costs of cancer
- Why so many cancers are diagnosed after they've metastasized
- How to make the business case for including multi-cancer early detection screenings as part of your benefit offering